Rapid Desensitization for Hypersensitivity Reactions to Chemotherapeutic Drugs; A Case Series.

Adverse drug reaction Cancer chemotherapy drugs Drug desensitization Drug hypersensitivity syndromes

Journal

Iranian journal of pharmaceutical research : IJPR
ISSN: 1735-0328
Titre abrégé: Iran J Pharm Res
Pays: Netherlands
ID NLM: 101208407

Informations de publication

Date de publication:
2019
Historique:
entrez: 19 9 2019
pubmed: 19 9 2019
medline: 19 9 2019
Statut: ppublish

Résumé

Usage of cancer chemotherapeutics drugs can be associated with adverse drug reactions. When IgE-mediated drug reactions are formed following administration of a chemotherapeutics drug that is a drug of choice, drug desensitization protocols can be helpful. HSR can be allergic or nonallergic, but the clinical manifestations are similar. RDD is effective when used appropriately, however it is often over utilized instead of performing a drug challenge. RDD is both an acceptable approach and a high-risk treatment modality in patients, in whom the offending agent is the first choice in chemotherapy. The safety of this modality has been acceptable in large studies. The side effects are often less frequent and less severe by repeating the protocol. We present 4 cases of successful desensitization in cancer patients, who have developed IgE- mediated reactions to their major chemotherapy drug.

Identifiants

pubmed: 31531085
doi: 10.22037/ijpr.1999.1100664
pmc: PMC6706720
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1047-1051

Références

Gynecol Oncol. 2001 Sep;82(3):550-8
pubmed: 11520154
J Clin Oncol. 2002 Feb 15;20(4):1146-7
pubmed: 11844841
Ann Allergy Asthma Immunol. 2004 Aug;93(2):137-41
pubmed: 15328672
Med Clin North Am. 2006 Jan;90(1):233-60
pubmed: 16310532
Curr Opin Allergy Clin Immunol. 2006 Dec;6(6):476-81
pubmed: 17088655
Ann Allergy Asthma Immunol. 2009 Feb;102(2):155-60
pubmed: 19230468
Immunol Allergy Clin North Am. 2009 Aug;29(3):585-606
pubmed: 19563999
J Allergy Clin Immunol. 2009 Dec;124(6):1259-66
pubmed: 19910036
J Allergy Clin Immunol. 2010 Mar;125(3):569-74, 574.e1-574.e7
pubmed: 20144472
BioDrugs. 2014 Apr;28(2):133-44
pubmed: 23990250
J Investig Allergol Clin Immunol. 2014;24(2):72-9; quiz 2 p following 79
pubmed: 24834769
Curr Oncol. 2014 Aug;21(4):e630-41
pubmed: 25089112
Case Reports Immunol. 2015;2015:524507
pubmed: 25685566
Ann Intern Med. 1981 Jan;94(1):66-72
pubmed: 7004302
Gynecol Oncol. 1994 Apr;53(1):121-2
pubmed: 8175010
J Allergy Clin Immunol. 1996 Jan;97(1 Pt 1):42-6
pubmed: 8568136

Auteurs

Delara Babaie (D)

Department of Immunology and Allergy, Mofid Children's Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Bibi Shahin Shamsian (BS)

Pediatric Congenital Hematologic Disorders Research Center, Mofid Children's Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Nader Momtazmanesh (N)

Department of Pediatric Hematology and Oncology, Loghman-e- Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Hamidreza Godarzipour (H)

Pediatric Congenital Hematologic Disorders Research Center, Mofid Children's Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Mehrdad Amirmoini (M)

Department of Immunology and Allergy, Mofid Children's Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Bahram Bashardoust (B)

Department of Immunology and Allergy, Mofid Children's Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Masoomeh Ebrahimi (M)

Department of Pediatrics, Loghman-e- Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Mahdieh Vahedi (M)

Department of Pediatrics, Mofid Children's Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Reza Ghaemi (R)

Department of Pediatrics, Urmia University of Medical Sciences, Urmia, Iran.

Mehrnaz Mesdaghi (M)

Department of Immunology and Allergy, Mofid Children's Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Classifications MeSH